301 related articles for article (PubMed ID: 24470514)
41. Immunogenic targets in non-small cell lung cancer: more is more.
Gnjatic S
Clin Cancer Res; 2005 Aug; 11(15):5331-2. PubMed ID: 16061843
[No Abstract] [Full Text] [Related]
42. A trial of autologous ex vivo-expanded NK cell-enriched lymphocytes with docetaxel in patients with advanced non-small cell lung cancer as second- or third-line treatment: phase IIa study.
Yang YJ; Park JC; Kim HK; Kang JH; Park SY
Anticancer Res; 2013 May; 33(5):2115-22. PubMed ID: 23645763
[TBL] [Abstract][Full Text] [Related]
43. Immunotherapy for lung cancer: for whom the bell tolls?
Madureira P; de Mello RA; de Vasconcelos A; Zhang Y
Tumour Biol; 2015 Mar; 36(3):1411-22. PubMed ID: 25736929
[TBL] [Abstract][Full Text] [Related]
44. Current immunotherapeutic strategies in lung cancer.
Rüttinger D; Hatz RA; Jauch KW; Fox BA
Surg Oncol Clin N Am; 2007 Oct; 16(4):901-18, x. PubMed ID: 18022551
[TBL] [Abstract][Full Text] [Related]
45. Immunotherapeutic strategies in non-small-cell lung cancer: the present and the future.
Steendam CM; Dammeijer F; Aerts JGJV; Cornelissen R
Immunotherapy; 2017 May; 9(6):507-520. PubMed ID: 28472903
[TBL] [Abstract][Full Text] [Related]
46. Vaccines in non-small cell lung cancer: rationale, combination strategies and update on clinical trials.
De Pas T; Giovannini M; Rescigno M; Catania C; Toffalorio F; Spitaleri G; Delmonte A; Barberis M; Spaggiari L; Solli P; Veronesi G; De Braud F
Crit Rev Oncol Hematol; 2012 Sep; 83(3):432-43. PubMed ID: 22366114
[TBL] [Abstract][Full Text] [Related]
47. Strategies for maintenance therapy in advanced non-small cell lung cancer: current status, unanswered questions and future directions.
Custodio A; de Castro J
Crit Rev Oncol Hematol; 2012 Jun; 82(3):338-60. PubMed ID: 21908201
[TBL] [Abstract][Full Text] [Related]
48. Incorporating Immunotherapy Into the Treatment of Non-Small Cell Lung Cancer: Practical Guidance for the Clinic.
Socinski MA
Semin Oncol; 2015 Oct; 42 Suppl 2():S19-28. PubMed ID: 26477471
[TBL] [Abstract][Full Text] [Related]
49. [Immuno-Oncology therapeutic principles in lung and renal cell carcinoma].
Wolf J; Grünwald V
Oncol Res Treat; 2014; 37 Suppl 4():10-3. PubMed ID: 25301191
[No Abstract] [Full Text] [Related]
50. Vaccines and immunotherapy for non-small cell lung cancer.
Morgensztern D; Goodgame B; Govindan R
J Thorac Oncol; 2010 Dec; 5(12 Suppl 6):S463-5. PubMed ID: 21102240
[No Abstract] [Full Text] [Related]
51. Role of immunotherapy in the treatment of advanced non-small-cell lung cancer.
Rijavec E; Genova C; Alama A; Barletta G; Sini C; Pronzato P; Coco S; Dal Bello MG; Savarino G; Truini A; Boccardo F; Grossi F
Future Oncol; 2014 Jan; 10(1):79-90. PubMed ID: 24328411
[TBL] [Abstract][Full Text] [Related]
52. Recent clinical trials of immunotherapy in non-small-cell lung cancer.
Gkolfinopoulos S; Mountzios G
Immunotherapy; 2019 Apr; 11(6):461-466. PubMed ID: 30860438
[No Abstract] [Full Text] [Related]
53. Immunotherapy in the treatment of non-small cell lung cancer.
Bílek O; Bořilová S; Grell P; Kiss I
Klin Onkol; 2021; 34(Supplementum 1):54-64. PubMed ID: 34154331
[TBL] [Abstract][Full Text] [Related]
54. Cytokine immunotherapy of non-small cell lung cancer.
Dubinett SM; Kradin RL
Reg Immunol; 1993; 5(3-4):232-43. PubMed ID: 8240940
[No Abstract] [Full Text] [Related]
55. Is vaccine therapy a renewed strategic approach for non-small-cell lung cancer therapy?
Rossi A
Expert Rev Vaccines; 2013 Jan; 12(1):5-7. PubMed ID: 23256734
[No Abstract] [Full Text] [Related]
56. Therapeutic cancer vaccines in the treatment of non-small-cell lung cancer.
Limacher JM; Spring-Giusti C; Bellon N; Ancian P; Rooke R; Bonnefoy JY
Expert Rev Vaccines; 2013 Mar; 12(3):263-70. PubMed ID: 23496666
[TBL] [Abstract][Full Text] [Related]
57. Immunotherapy Comes of Age in Lung Cancer.
Khanna P; Blais N; Gaudreau PO; Corrales-Rodriguez L
Clin Lung Cancer; 2017 Jan; 18(1):13-22. PubMed ID: 27461776
[TBL] [Abstract][Full Text] [Related]
58. The state of the art in non-small cell lung cancer immunotherapy.
Seetharamu N
Semin Thorac Cardiovasc Surg; 2014; 26(1):26-35. PubMed ID: 24952755
[TBL] [Abstract][Full Text] [Related]
59. [The role of immune checkpoint inhibitors in lung cancer: from clinical trials to clinical practice].
Wang ZM; Song Y
Zhonghua Jie He He Hu Xi Za Zhi; 2020 Feb; 43(2):95-99. PubMed ID: 32062879
[TBL] [Abstract][Full Text] [Related]
60. Non-small-cell lung cancer vaccine therapy: a concise review.
O'Mahony D; Kummar S; Gutierrez ME
J Clin Oncol; 2005 Dec; 23(35):9022-8. PubMed ID: 16219932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]